The ongoing controversy surrounding the safety of using TASER® electrical stun guns took a new turn today when a team of cardiologists at the University of California, San Francisco announced findings suggesting that much of the current TASER®-related safety research may be biased due to ties to the devices’ manufacturer, TASER International, Inc.
May 04, 2011
Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease.
March 01, 2011
Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.
February 03, 2011
UCSF Nobel laureate Elizabeth Blackburn is not ready to predict how long you will live. But she and her UCSF colleagues are exploring a feature within cells that is a kind of hourglass for aging.
December 16, 2010
Cystatin C, a blood marker of kidney function, proved significantly more accurate than the standard blood marker, creatinine, in predicting serious complications of kidney disease, in a study by researchers at the San Francisco VA Medical Center and UCSF.
November 17, 2010
Scientists are reporting the first direct evidence that a subtle change in the physical properties of a tissue can affect its function.
November 15, 2010
Cutting back on salt in teenagers’ diets by as little as one-half teaspoon, or three grams, a day, could reduce the number of young adults with high blood pressure by 44 to 63 percent, according to new research presented Sunday, Nov. 14 at the American Heart Association’s Scientific Sessions 2010 meeting in Chicago.
November 15, 2010
UCSF researchers have for the first time shown that an external optical pacemaker can be used in a vertebrate to control its heart rate.
November 02, 2010
New technologies and techniques continue to accelerate the pace of discovery in human genetics research, a fact made clear by scientists who spoke about their searches for important mutations, gene variants and answers to basic biological questions at the UCSF Institute for Human Genetics’ fifth-anniversary symposium on Oct. 28.
September 28, 2010
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.